NCT05170204
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05170204
Title A Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer (NSCLC) (HORIZON 1)
Acronym HORIZON 1
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | SWE | POL | ITA | GBR | FRA | DEU | BRA | BEL | AUS

Facility Status City State Zip Country Details
Northwest Cancer Specialists, P.C. Tigard Oregon 97223 United States Details
Hillman Cancer Center Pittsburgh Pennsylvania 15232 United States Details
Peter MacCallum Cancer Centre Melbourne Victoria 3000 Australia Details
One Clinical Research Nedlands Western Australia 6009 Australia Details
UZ Gent Ghent 9000 Belgium Details
Hospital de Cancer de Barretos Barretos São Paulo 14784-400 Brazil Details
Instituto do Cancer do Estado de Sao Paulo - ICESP São Paulo São Paulo 01246-000 Brazil Details
RedSalud Vitacura Santiago Chile Details
Hunan Cancer Hospital Changsha 410013 China Details
Xinqiao Hospital of Third Military Medical University Chongqing 400037 China Details
Shandong Cancer Hospital Jinan 250117 China Details
Shanghai Pulmonary Hospital Shanghai 200433 China Details
Fundación CTIC - Centro de Tratamiento e Investigación sobre Cáncer Luis Carlos Sarmiento Angulo Bogota, D.C. 110131 Colombia Details
Hospital Universitario San Ignacio Bogotá 000472 Colombia Details
Centre Francois Baclesse Caen 14000 France Details
Centre Leon Berard Lyon 69008 France Details
Hopital Nord Marseille 13915 France Details
Helios Klinikum Emil von Behring GmbH Berlin 14165 Germany Details
IRST Istituto Scientifico Romagnolo Per Lo Studio E Cura Dei Tumori, Sede Meldola Meldola Emilia-Romagna 47014 Italy Details
Asst Grande Ospedale Metropolitano Niguarda Milan Lombardy 20162 Italy Details
NHO Kyushu Cancer Center Fukuoka 811-1395 Japan Details
Kurume University Hospital Fukuoka 830-0011 Japan Details
Kobe City Medical Center General Hospital Hyōgo 650-0047 Japan Details
Kagoshima University Hospital Kagoshima 890-8520 Japan Details
Kumamoto University Hospital Kumamoto 860-8556 Japan Details
Kindai University Hospital Ōsaka-sayama 589-8511 Japan Details
Juntendo University Hospital Tokyo 113-8431 Japan Details
The Cancer Institute Hospital of JFCR Tokyo 135-8550 Japan Details
Hospital Civil de Guadalajara Fray Antonio Alcalde Guadalajara Jalisco 44280 Mexico Details
Dolno?l?skie Centrum Chorób P?uc we Wroc?awiu Wroc?aw 53-439 Poland Details
National Cancer Centre Singapore 168583 Singapore Details
Kyungpook National University Chilgok Hospital Daegu 41404 South Korea Details
Pusan National University Yangsan Hospital Gyeongsangnam-do 50612 South Korea Details
Chonnam National University Hwasun Hospital Jeollanam-do 58128 South Korea Details
Seoul National University Bundang Hospital Seongnam-si 13605 South Korea Details
Asan Medical Center Seoul 05505 South Korea Details
Korea University Guro Hospital Seoul 08308 South Korea Details
Sahlgrenska University Hospital Gothenburg 413 45 Sweden Details
Karolinska Universitetssjukhuset, Solna Stockholm 171 76 Sweden Details
Taichung Veterans General Hospital Taichung 40705 Taiwan Details
Rajavithi Hospital Bangkok 10400 Thailand Details
Faculty of Med. Siriraj Hosp. Bangkok 10700 Thailand Details
Oncology Unit, Faculty of Medicine, Vajira Hospital Dusit 10300 Thailand Details
Songklanagarind Hospital Songkhla 90110 Thailand Details
Christie Hospital Nhs Trust Manchester M2O 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field